If you or someone you know struggles with memory loss issues, mild cognitive impairment, or early stage dementia, and you are interested in being part of a clinical trial, please reach out by filling out the form below. 

Participants must reside in DFW, Texas area to be eligible for this trial.

*Planned start in 2026*

This study explores how personalized, genomics-guided interventions influence biological aging, health span, and longevity. By integrating clinical assessments, molecular biomarkers, and advanced genetic insights, Longevitate aims to identify individualized patterns of aging and develop optimized strategies to slow or reverse age-related decline.

​

*Planned start in late 2026-2027*

Longevitate is actively developing new medical devices and technologies for future use. 
We’re inviting clinicians, researchers, engineers, and industry partners to collaborate in shaping the future of precision and longevity medicine.